Evaluation of Benefit and Tolerability of IQP-CL-101 (Xanthofen) in the Symptomatic Improvement of Irritable Bowel Syndrome: A Double-Blinded, Randomised, Placebo-Controlled Clinical Trial
2017 ◽
Vol 31
(7)
◽
pp. 1056-1062
◽
Felix Alt
◽
Pee-Win Chong
◽
Emily Teng
◽
Ralf Uebelhack
Mahsa Miryan
◽
Pezhman Alavinejad
◽
Mohammadreza Abbaspour
◽
Davood Soleimani
◽
Alireza Ostadrahimi
2011 ◽
Vol 140
(5)
◽
pp. S-50
◽
Pierre Desreumaux
◽
Christel Neut
◽
Murielle Cazaubiel
◽
Pichelin Matthieu
◽
Pelerin Fanny
◽
...
2016 ◽
Vol 24
(9)
◽
pp. 645-652
◽
Xu-dong Tang
◽
Bin Lu
◽
Zhen-hua Li
◽
Wei Wei
◽
Li-na Meng
◽
...
1990 ◽
Vol 31
(3)
◽
pp. 355-358
◽
G Dobrilla
◽
B P Imbimbo
◽
L Piazzi
◽
G Bensi
2018 ◽
Vol 154
(6)
◽
pp. S-130
◽
Tom Holvoet
◽
Marie Joossens
◽
Boelens Jerina
◽
Evelien Christiaens
◽
Lander Heyerick
◽
...
2010 ◽
Vol 2
(4)
◽
pp. 187-187
B Brinkhaus
◽
C Hentschel
◽
M Lindner
◽
G Schindler
◽
J Bauer
◽
...
2019 ◽
Vol 10
(1)
◽
pp. 16
Azita Hekmatdoost
◽
Mahsa Jalili
◽
Homayoon Vahedi
◽
Hossein Poustchi
2016 ◽
Vol 14
(4)
◽
pp. 343
◽
Vinay G Zanwar
◽
Sunil V Pawar
◽
Pravir A Gambhire
◽
Samit S Jain
◽
Ravindra G Surude
◽
...
2010 ◽
Vol 16
(1)
◽
pp. 47-52
◽
Claas Lahmann
◽
Frank Röhricht
◽
Nina Sauer
◽
Michael Noll-Hussong
◽
Joram Ronel
◽
...
Close
Export Citation Format
Close
Share Document
Close